Aptevo Therapeutics Inc. Prepaid Expense and Other Assets, Current
Aptevo Therapeutics Inc. (APVO) had Prepaid Expense and Other Assets, Current of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.00M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.46M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.46M.
- 2024-12-31: Prepaid Expense and Other Assets, Current $1.95M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.46M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.46M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $1.95M 10-K · filed 2026-03-26 |
| 2017-09-30 | $6.38M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $5.87M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $6.12M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $5.57M 10-Q · filed 2017-11-13 |
| 2016-09-30 | $3.82M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $3.91M 10-Q/A · filed 2016-09-22 |
| 2015-12-31 | $2.34M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |